|
Multimedia
Images, audio, and video related to cancer research
Calendar
Meetings, seminars, and press conferences focused on cancer research
Resources
Information on cancer types, treatment, prevention, and more
 Sponsored by:
The Cancer News Portal is supported by the National Cancer Institute of the National Institutes of Health. Additional information on cancer research, prevention, and treatment is available at www.cancer.gov |
Breaking News
Key: Meeting
Showing releases 1101-1124 out of 1124. << < 40 | 41 | 42 | 43 | 44 | 45
Public Release: 11-Jun-2012
2012 Society of Nuclear Medicine Annual MeetingHave no fear: Most cases of thyroid cancer do not affect survival Research presented at the Society of Nuclear Medicine's 59th Annual Meeting reveals that patients with differentiated thyroid cancer live as long as people in perfect health, unless they are in the minority and have reached the most advanced stages of disease. Survival did not vary based on age, sex, or even if patients' cancer had reached the beginning of stage IV. Contact: Susan Martonik
Public Release: 11-Jun-2012
2012 Society of Nuclear Medicine Annual MeetingPET imaging could lead to better care for neuroendocrine cancer A method of molecular imaging that pinpoints hormonally active tissues in the body could change the course of treatment for a remarkable number of neuroendocrine cancer patients, say researchers at the Society of Nuclear Medicine's 59th Annual Meeting. Contact: Susan Martonik
Public Release: 10-Jun-2012
 NatureDecoding DNA finds breast tumor signatures that predict treatment response Decoding the DNA of patients with advanced breast cancer has allowed scientists to identify distinct cancer "signatures" that could help predict which women are most likely to benefit from estrogen-lowering therapy, while sparing others from unnecessary treatment. 
NIH/National Cancer Institute, NIH/National Human Genome Research Institute, Susan G. Komen for the Cure, Fashion Footwear Charitable Foundation Inc.
Contact: Caroline Arbanas
Public Release: 10-Jun-2012
Euroanaesthesia 2012Quick, simple test developed to identify patients who will not respond to the painkiller tramadol French researchers have found a way to identify quickly the five-ten percent of patients in whom the commonly used painkiller, tramadol, does not work effectively. A simple blood test can produce a result within a few hours, enabling doctors to switch a non-responding patient on to another painkiller, such as morphine, which will be able to work in these patients. The research will be presented to the European Anaesthesiology Congress in Paris on Sunday.
Hospital Clinical Research Program
Contact: Emma Mason
Public Release: 10-Jun-2012
Nature Chemical BiologyScripps Research scientists develop new tools to unveil mystery of the 'glycome' Scientists at the Scripps Research Institute have developed chemical compounds that can make key modifications to common sugar molecules ("glycans"), which are found on the surface of all cells in our body.
National Institutes of Health
Contact: Mika Ono
Public Release: 8-Jun-2012
Journal of the National Cancer InstituteProbing the mechanism of ADAM28-mediated cancer metastasis ADAM28, a metalloproteinase belonging to the ADAM gene family, cleaves the von Willebrand factor (VWF) and inhibits VWF-mediated cancer cell apoptosis, thereby enhancing lung metastases, so inhibiting its expression gives a substantial reduction in lung metastases, according to a study published June 8 in the Journal of The National Cancer Institute. Contact: Zachary Rathner
Public Release: 8-Jun-2012
ASTRO chairman to testify at CARE Act hearing American Society for Radiation Oncology Chairman Leonard Gunderson, M.D., M.S., FASTRO, will testify before the House Committee on Energy and Commerce Subcommittee on Health today on provisions of the Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2011 (CARE Act) related to training and credentialing for medical imaging and radiation therapy technologists. Contact: Nicole Napoli
Public Release: 8-Jun-2012
Cancer Immunology, ImmunotherapyMoffitt Cancer Center researchers develop and test new anti-cancer vaccine Researchers at Moffitt Cancer Center have developed and tested in mice a synthetic vaccine and found it effective in killing human papillomavirus-derived cancer, a virus linked to cervical cancers among others. The research was published in a recent issue of Cancer Immunology, Immunotherapy.
National Institutes of Health
Contact: Patty Kim
Public Release: 8-Jun-2012
Journal of Cell ScienceOverexpression of proteins 14-3-3 related to chemotherapy resistance Certain proteins, such as 14-3-3, conserve their basic functions of cell cycle control in diverse organisms, from worms to humans. In a study led by Julián Cerón and Simó Schwartz Jr, researchers from the Bellvitge Biomedical Research Institute and the Research Institute of Vall d'Hebron respectively, have described germ line functions of par-5, which is one of the two 14-3-3 proteins existing in Caenorhabditis elegans, worms used as experimental model in genetic studies. Contact: Raül Toran
Public Release: 8-Jun-2012
2012 Society of Nuclear Medicine Annual MeetingPiramal Imaging to present data at Society for Nuclear Medicine Annual Meeting Piramal Imaging SA, a subsidiary of Piramal Healthcare Limited, will present data on several compounds from its molecular imaging portfolio at the Society of Nuclear Medicine's 59th annual meeting in Miami Beach, Fla., from June 9 - 13. Data from five florbetaben studies will be featured, including results from a pivotal Phase III trial which will provide the basis for regulatory submission later this year. Contact: Julie Armour
Public Release: 7-Jun-2012
Journal of Health Care for the Poor and Underserved2-1-1 could be effective tool in fighting cancer disparities The 2-1-1 phone information and referral system could be a key partner in efforts to reduce cancer disparities affecting low-income and racial and ethnic minorities in the US, finds a new study by Jason Purnell, Ph.D., assistant professor of public health at the Brown School at Washington University in St. Louis. Contact: Jessica Martin
Public Release: 7-Jun-2012
PLOS GeneticsStudy sheds new light on role of genetic mutations in colon cancer development In exploring the genetics of mitochondria -- the powerhouse of the cell -- researchers at Fred Hutchinson Cancer Research Center have stumbled upon a finding that challenges previously held beliefs about the role of mutations in cancer development. For the first time, researchers have found that the number of new mutations are significantly lower in cancers than in normal cells.
NIH/National Institute of Environmental Health Sciences, Ellison Medical Foundation, Fred Hutchinson Cancer Research Center
Contact: Kristen Woodward
Public Release: 7-Jun-2012
NatureMount Sinai researchers develop a multi-target approach to treating tumors Researchers from Mount Sinai School of Medicine developed a cancer model built in the fruit fly Drosophila, then used it to create a whole new approach to the discovery of cancer treatments. The result is an investigational compound AD80 that precisely targets multiple cancer genes. Contact: Mount Sinai Press Office
Public Release: 7-Jun-2012
ScienceNew discovery provides insight on long-standing pregnancy mystery Researchers at NYU School of Medicine have made an important discovery that partially answers the long-standing question of why a mother's immune system does not reject a developing fetus as foreign tissue.
National Institutes of Health, American Cancer Society
Contact: Jessica Guenzel
Public Release: 6-Jun-2012
Biology of Reproduction3 types of fetal cells can migrate into maternal organs during pregnancy A pregnant woman's blood stream contains not only her own cells, but a small number of her child's, as well, and some of them remain in her internal organs long after the baby is born. Understanding the origin and identity of these cells is vital to understanding their potential effects on a mother's long-term health.
NIH/National Institute of Child Health and Human Development, Provost Fund at Tufts University, Sackler Dean's Fellowship Award
Contact: Jeremy Lechan
Public Release: 6-Jun-2012
Proceedings of the National Academy of SciencesResearchers at IRB Barcelona uncover new clues about the origin of cancer A study by researchers at the Institute for Research in Biomedicine, in collaboration with scientists at the Memorial Sloan Kettering Cancer Center, reveals new information about the origin of tumors. In this study, the scientists postulate that the initiation of a tumor and the type and aggressivity of the same depend on a specific combination of defects in several processes that safeguard cell integrity, such as DNA repair pathways and cell cycle check-points. Contact: Sňnia Armengou
Public Release: 6-Jun-2012
New England Journal of MedicineNew drug found effective against rare form of basal cell skin cancer A clinical study has demonstrated that a new drug, a targeted molecular therapy called vismodegib (trade name Erivedge), can dramatically shrink basal cell skin cancers and prevent the formation of new ones, in patients with basal cell nevus syndrome. The phase II clinical study, led by researchers at NewYork-Presbyterian Hospital/Columbia University Medical Center and Children's Hospital of Oakland Research Institute, was published today in the online edition of the New England Journal of Medicine.
National Institutes of Health, NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases, Damon Runyon Cancer Research Foundation, Swim Across America Foundation, Genentech
Contact: Elizabeth Streich
Public Release: 6-Jun-2012
European Physical Journal EModeling the demise of migrating brain tumor cells An Israeli physicist has developed a theoretical model to simulate the evolution of highly proliferating brain tumor core cells subjected to treatment by alternating radio frequency electric field. The research, by Alexander Iomin from the Israel Institute of Technology Technion in Haifa, is about to be published in EPJ E. In another model, the author examines the possibility of enhancing the level of treatment by targeting the outer area of the tumor. Contact: Janine Haubenreisser
Public Release: 6-Jun-2012
Disease Models & MechanismsUC Davis scientists find new role for P53 genetic mutation -- initiation of prostate cancer A team of UC Davis investigators has found that a genetic mutation may play an important role in the development of prostate cancer. Contact: Dorsey Griffith
Public Release: 6-Jun-2012
Cancer ResearchHIV drug may slow down metastatic breast cancer, say researchers at Jefferson's Kimmel Cancer Center The HIV drugs known as CCR5 antagonists may also help prevent aggressive breast cancers from metastasizing, researchers from the Kimmel Cancer Center at Jefferson suggest in a preclinical study published in a recent issue of Cancer Research. Contact: Steve Graff
Public Release: 5-Jun-2012
Nature Structural & Molecular BiologyIdentified an anti-oncogene into an oncogene A study coordinated by Manel Esteller, Director of the program of epigenetics and cancer biology at the Bellvitge Institute for Biomedical Research, Professor of genetics at the University of Barcelona and ICREA researcher, has discovered the existence of an antitumor molecule that originates within an oncogene. The finding is published this week in the Nature Structural & Molecular Biology journal. Contact: Raül Toran
Public Release: 5-Jun-2012
BloodType 2 diabetes linked to increased blood cancer risk, say Miriam Hospital researchers A new meta-analysis by Miriam Hospital researchers reveals patients with type 2 diabetes have a 20 percent increased risk of developing blood cancers.
NIH/National Center for Research Resources
Contact: Jessica Collins Grimes
Public Release: 5-Jun-2012
PETA to FDA: Don't let more animals suffer and die for tobacco products PETA today submitted official comments to the Food and Drug Administration regarding the agency's Draft Guidance for Industry: Modified Risk Tobacco Product (MRTP) Applications, which, as currently written, will lead to animal studies being conducted in support of MRTP applications. PETA, along with hundreds of consumers who submitted comments to the FDA through an action alert on PETA's popular website, is calling on the FDA to amend its guidance to recommend using only modern, effective non-animal testing methods. Contact: Jessica Sandler
Public Release: 5-Jun-2012
New Firefly technology lights up more precise kidney sparing surgery During kidney surgery, Firefly fluorescence used with the da Vinci robot lights up in "firefly green" the blood supply to the kidney and helps differentiate cancerous from healthy tissue. More patients can keep the healthy part of their kidney rather than losing the entire organ. Contact: Marianne Worley
Showing releases 1101-1124 out of 1124. << < 40 | 41 | 42 | 43 | 44 | 45
|
Search News Releases
|
||||||||||||||||||||||||
 |
||||
|
|
 |
|